Skip to main content
. 2011 Mar 11;103(6):478–488. doi: 10.1093/jnci/djr027

Figure 4.

Figure 4

Cumulative incidence of invasive ipsilateral breast tumor recurrences within categories of margin status and treatment in the National Surgical Adjuvant Breast and Bowel Project B-24 trial. Treatment groups were lumpectomy with radiation therapy plus 5 years of placebo (LRT + placebo) or tamoxifen (LRT + TAM), without tumor at margins, or with involved or unknown tumor at margins as defined in the B-24 trial.